XML 57 R41.htm IDEA: XBRL DOCUMENT v3.3.1.900
Derivative Financial Instruments (Tables)
12 Months Ended
Dec. 27, 2015
Derivative Financial Instruments [Abstract]  
Summary of Cash Flow Hedging Instruments
At December 27, 2015 and December 28, 2014, the notional amounts and fair values of assets (liabilities) for the Company's foreign currency forward contracts designated as cash flow hedging instruments were as follows:
 
2015
 
2014
    
Hedged transaction
Notional
Amount
 
Fair
Value
 
Notional
Amount
 
Fair
Value
Inventory purchases
$
1,380,488
 
108,521
 
863,232
 
69,049
         
Sales
 
97,350
 
803
 
139,946
 
829
Royalties and Other
 
54,360
 
(1,886)
 
51,213
 
(1,008)
Total
$
1,532,198
 
107,438
 
1,054,391
 
68,870

Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location
The Company has a master agreement with each of its counterparties that allows for the netting of outstanding forward contracts. The fair values of the Company's foreign currency forward contracts designated as cash flow hedges are recorded in the consolidated balance sheet at December 27, 2015 and December 28, 2014 as follows:

 
2015
 
2014
Prepaid expenses and other current assets
    
Unrealized gains
$
78,910
 
46,594
Unrealized losses
 
(5,932)
 
(11,508)
Net unrealized gain
$
72,978
 
35,086
     
Other assets
    
Unrealized gains
$
35,366
 
34,234
Unrealized losses
 
(710)
 
(172)
Net unrealized gain
$
34,656
 
34,062
     
Accrued liabilities
    
Unrealized gains
$
-
 
447
Unrealized losses
 
-
 
(725)
Net unrealized loss
$
-
 
(278)
     
Other liabilities
    
Unrealized gains
$
241
 
-
Unrealized losses
 
(437)
 
-
Net unrealized loss
$
(196)
 
-
     

Schedule of Derivative Instruments, Gain (Loss) in Statement of Operations
Net gains (losses) on cash flow hedging activities have been reclassified from other comprehensive earnings to net earnings for the years ended December 27, 2015, December 28, 2014 and December 29, 2013 as follows:

 
2015
  
2014
  
2013
 
Consolidated Statements of Operations Classification
        
Cost of sales
 $
66,378
   
973
  
1,523
 
Sales
 
(9,219)
   
(3,741)
  
3,585
 
Royalties and other
 
(566)
   
(2,028)
  
(1,096)
 
Net realized (losses) gains
 $
56,593
   
(4,796)
  
4,012
 

Fair Values of Undesignated Derivative Financial Instruments

At December 27, 2015 and December 28, 2014, the fair value of the Company's undesignated derivative financial instruments are recorded to accrued liabilities in the consolidated balance sheets as follows:
 
2015
 
2014
Accrued liabilities
    
Unrealized gains
$
416
 
1,733
Unrealized losses
 
(1,460)
 
(4,046)
Net unrealized loss
$
(1,044)
 
(2,313)